Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-23

Clinical Trial Update: Plerixafor for Stem Cell Mobilization in Normal Donors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating plerixafor for stem cell mobilization in normal donors has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Plerixafor (Plerixafor)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Blood And Marrow Transplantation | Phase 2 | Status: COMPLETED | Results posted: 2019-04-23